SIRT1:可能是未来疼痛管理治疗策略的关键
Sara Ilari1, Saverio Nucera2, Lucia Carmela Passacatini3
1IRCCS San Raffaele Roma, Rome 00166, Italy; Department of Human Sciences and Quality of Life Promotion, Università Telematica San Raffaele, Rome 00166, Italy.
Pharmacological research
|February 21, 2025
概括
贝加莫特多分离物 (BPF) 保持了Sirtuin 1 (SIRT1) 的活性,减少了氧化应激和炎症. 这种营养药可以通过调节SIRT1来缓解疼痛,这可能会导致慢性疼痛和长期COVID疾病.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 赛尔图因1 (SIRT1) 对于减轻氧化应激,炎症和线粒体功能至关重要.
- 减少SIRT1活性与长期COVID病理有关,其特征是炎症和线粒体功能障碍.
- 氧化应激,标志着活性氧物种 (ROS) 的增加,驱动炎症和疼痛敏感性.
研究的目的:
- 在一种炎症性疼痛模型中,研究柏格玛托多分数 (BPF) 对SIRT1活性的影响.
- 探索SIRT1化在炎症性疼痛病原发生中的作用.
- 评估BPF作为氧化应激和炎症驱动疼痛的治疗剂的潜力.
主要方法:
- 使用了一种炎症和过敏症的老鼠模型.
- 评估SIRT1活性和翻译后的修改 (化,乙化,碳化).
- 测量了氧化应激标志物,包括麦隆迪化 (MDA) 和8-二氧化氨 (8-OHdG).
主要成果:
- 施用BPF可保持SIRT1活性,并降低氧化应激标志物 (MDA,8-OHdG).
- BPF将核蛋白的有害的翻译后修改最小化.
- 治疗BPF缓解了过敏症和全音症,表明疼痛缓解.
结论:
- SIRT1化是炎症性疼痛的一个关键事件.
- 通过保持SIRT1活性和减少氧化应激,BPF显示出治疗潜力.
- BPF为管理炎症和疼痛提供了一个有希望的途径,可能有利于长期COVID等疾病.
相关概念视频
01:25Analgesia and Pain Management
422
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
422
01:44Nociception
27.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.6K